Psychometric properties of the behavior rating inventory of executive function, second edition (BRIEF2) in a sample of children with ADHD in Iran

Parhoon, Kamal; Moradi, Alireza; Alizadeh, Hamid; Parhoon, Hadi; Sadaphal, Dhwani P.; Coolidge, Frederick L.

doi:10.1080/09297049.2021.1975669

Cited by 14 publications

(16 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similarly, a correlation of 0.83 was reported between behavioural and emotionl factors of the BRIEF in a mixed healthy and clinical sample (Egeland & Fallmyr 2010). Further, a large correlation between BRI and ERI was also found in a study that supported the three-factor model of the BRIEF2 in children with ADHD (Parhoon et al 2022). Thus, separating BRI from ERI and conceptualising them as distinct components may provide meaningful explanatory value for the BRIEF2 among youth with DS.…”

Section: Two-factor Model Versus Three-factor Modelmentioning

confidence: 64%

“…However, using CFA in a large mixed clinical sample of children with ADHD, adjustment disorders, anxiety disorders, encephalopathy, oncologic diseases, epilepsy, and oppositional defiant disorder or conduct problems, Jacobson et al (2020) reported the three-factor model of the BRIEF2 (CRI, BRI, and ERI) demonstrates the best fit, although analyses including items, scales, and indices suggested not more than six interpretable scales. Likewise, in a sample of children with ADHD, results of a CFA showed that the three-factor structure of the BRIEF2 (CRI, BRI, and ERI) was the best fitting model (Parhoon et al 2022).…”

Section: Factor Structure Of the Brief And Brief2 In Clinical Samplesmentioning

confidence: 98%

“…In summary, there are inconsistent results regarding the factor structure of the BRIEF and BRIEF2 with mixed clinical samples. While some studies supported the three-factor structure of the BRIEF (Gioia & Isquith 2002;Lace et al 2019) and the BRIEF2 (Jacobson et al 2020;Parhoon et al 2022), others reported that two-factor model best explains the factor structure of the BRIEF (Lyons Usher et al 2016;Memisevic 2015;Slick et al 2006) and BRIEF2 (Lace et al 2021). Such inconsistency may reflect the unique EF structure in specific clinical samples.…”

Section: Factor Structure Of the Brief And Brief2 In Clinical Samplesmentioning

confidence: 99%

“…Even more recently, the proposed factor structures (one-, two-, and three-factor models) were examined with some mixed and specific clinical samples by using the updated version of the BRIEFthe BRIEF2 (Jacobson et al 2020;Lace et al 2021;Parhoon et al 2022). Using CFA, Lace et al (2021) reported that the bifactor two-factor structure of the BRIEF2 (CRI & BRI/ERI) provided the best fit in a mixed clinical sample of children with ASD, cerebral palsy, brain tumours, unspecified neurodevelopmental disorders, ADHD, psychiatric (e.g.…”

Section: Factor Structure Of the Brief And Brief2 In Clinical Samplesmentioning

confidence: 99%

See 3 more Smart Citations

Confirmatory factor analysis of the BRIEF2 in a sample of youth with Down syndrome

Soltani

Schworer

Jacobson

et al. 2022

J intellect Disabil Res

View full text Add to dashboard Cite

Background The factor structure of the Behavior Rating Inventory of Executive Function, second edition (BRIEF2) has been widely examined in both typically developing children and specific clinical samples. Despite the frequent use of the BRIEF2 for measuring executive functioning in individuals with Down syndrome, no study has investigated the factorial validity or dimensionality of the BRIEF2 in this population. This study aimed to address this notable gap in the literature. Methods Parents of 407 children and youth with Down syndrome aged 6-18 years completed the BRIEF2 as part of different studies led by six sites. Three competing models proposed by previous studies were analysed using Confirmatory Factor Analysis: the theoretical structure of the BRIEF2 where the scales were constrained to load on three factors labelled as Cognitive, Behavioral, and Emotional Regulation, a two-factor correlated model with the merged Behavioral and Emotional regulation, and a single-factor model. ResultsThe three-factor model provided a better fit than the one-and two-factor models, yet a large correlation was observed between Behavioural and Emotional regulation factors. The results provide meaningful explanatory value for the theoretical structure of the BRIEF2. However, the Behavioral and Emotional regulation factors might be less differentiated and the two-factor structure of the BRIEF2 may also make theoretical and empirical sense. Conclusions Although more studies are needed to further examine the factor structure of the BRIEF2 in youth with Down syndrome, this investigation provides preliminary support for the interpretation of the three executive function index scores provided by the BRIEF2: Cognitive, Behavioral, and Emotional Regulation.

show abstract

Section: Two-factor Model Versus Three-factor Modelmentioning

confidence: 64%

Section: Factor Structure Of the Brief And Brief2 In Clinical Samplesmentioning

confidence: 98%

Section: Factor Structure Of the Brief And Brief2 In Clinical Samplesmentioning

confidence: 99%

Section: Factor Structure Of the Brief And Brief2 In Clinical Samplesmentioning

confidence: 99%

See 2 more Smart Citations

Confirmatory factor analysis of the BRIEF2 in a sample of youth with Down syndrome

Soltani

Schworer

Jacobson

et al. 2022

J intellect Disabil Res

View full text Add to dashboard Cite

show abstract

“…This test shows adequate psychometric properties. The BRIEF-2 has demonstrated good reliability (internal and test–retest) and satisfactory to good convergent and construct validity in different countries, including Spain [ 33 , 34 ]…”

Section: Methodsmentioning

confidence: 99%

Effectivity of Saffron Extract (Saffr’Activ) on Treatment for Children and Adolescents with Attention Deficit/Hyperactivity Disorder (ADHD): A Clinical Effectivity Study

et al. 2022

View full text Add to dashboard Cite

Attention Deficit/Hyperactivity Disorder is the most prevalent neurodevelopmental disorder worldwide. Choice treatment includes psychostimulants, but parents tend to be reluctant to administer them due to side effects, and alternatives are needed. Saffron extract is a natural stimulant that has been proven safe and effective for treating a variety of mental disorders. This study compares the efficacy of saffron and the usual treatment with methylphenidate, using objective and pen-and-paper tests. We performed a non-randomized clinical trial with two groups, methylphenidate (n = 27) and saffron (n = 36), in children and adolescents aged 7 to 17. Results show that the efficacy of saffron is comparable to that of methylphenidate. Saffron is more effective for treating hyperactivity symptoms, while methylphenidate is more effective for inattention symptoms.

show abstract

Longitudinal Effects of Cumulative Adverse Childhood Experiences on Internalizing and Externalizing Problems in Adolescents in Out-of-Home Care: Emotion Dysregulation as a Mediator

Zhou,

Chew,

Oei

et al. 2024

ADV RES SCI

View full text Add to dashboard Cite

Psychometric properties of the behavior rating inventory of executive function, second edition (BRIEF2) in a sample of children with ADHD in Iran

Cited by 14 publications

References 26 publications

Confirmatory factor analysis of the BRIEF2 in a sample of youth with Down syndrome

Confirmatory factor analysis of the BRIEF2 in a sample of youth with Down syndrome

Effectivity of Saffron Extract (Saffr’Activ) on Treatment for Children and Adolescents with Attention Deficit/Hyperactivity Disorder (ADHD): A Clinical Effectivity Study

Longitudinal Effects of Cumulative Adverse Childhood Experiences on Internalizing and Externalizing Problems in Adolescents in Out-of-Home Care: Emotion Dysregulation as a Mediator

Contact Info

Product

Resources

About